Filter
1383
Text search:
World
Health
Organization
WHO
and
World
Intellectual
Property
Organization
Featured
204
283
Language
Document type
361
339
317
187
99
43
27
6
3
1
Countries
140
23
21
20
20
17
14
14
13
11
11
11
10
10
9
9
8
8
8
8
8
7
7
7
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
229
197
147
116
108
49
40
Toolboxes
130
106
82
80
79
72
71
69
64
55
43
43
36
35
31
30
28
17
15
7
6
5
5
5
3
Long-term planning for an adequate and safe supply of drinking-water should be set in the context of growing external uncertainties arising from changes in the climate and environment. The water sa
...
Ensuring mental health and well-being has become a worldwide imperative and an important target
of the Sustainable Development Goals.
But in all
...
at the World Trade Organization (WTO) Trade Related Aspects of Intellectual Property Rights (TRI
...
Urbanization, land use, global trade and industrialization have led to profound and negative impacts on nature, biodiversity and ecosystems across
...
Global concerns: Implications for the future
Child Mental Health Atlas
The text is a report from a WHO meeting that focuses on strengthening research in the field of health emergency and disaster risk management (
...
Framework for Action
January 2020 to December 2021
Annex 5, WHO Technical Report Series 1010, 2018
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal
...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with
...
